Innovation – Europabio

23/05/2023

23/05/2023

EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation

10/05/2023

10/05/2023

#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee

10/05/2023

10/05/2023

Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski

13/12/2022

13/12/2022

EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.

28/11/2022

28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.

11/11/2022

11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

20/10/2022

20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

19/10/2022

19/10/2022

#EFIB2022: Industrial biotechnology community comes together in Vilnius next week

06/10/2022

06/10/2022

EuropaBio celebrates its inaugural Healthcare BioForum

03/10/2022

03/10/2022

Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio

21/09/2022

21/09/2022

Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer

21/09/2022

21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Tineke Van hooland, bio.be/essenscia

21/09/2022

21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Thomas Bols, PTC Therapeutics

06/07/2022

06/07/2022

Value of Biotech

27/06/2022

27/06/2022

Unlocking the Promise of Gene Therapy

25/05/2022

25/05/2022

European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi

04/04/2022

04/04/2022

EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology

28/02/2022

28/02/2022

EuropaBio Statement on Rare Disease Day

13/12/2021

13/12/2021

Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA

EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform.

22/11/2021

22/11/2021

The review of the general pharmaceutical legislation: an opportunity that should not be missed?

26/10/2021

26/10/2021

Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem

19/10/2021

19/10/2021

EuropaBio Patient Bio-Forum: challenges and future potential of European Reference Networks

30/09/2021

30/09/2021

Artificial intelligence: investing in new technologies in healthcare

What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?